Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 17 March 2000:
Vol. 287. no. 5460, pp. 1956 - 1958
DOI: 10.1126/science.287.5460.1956
Prev | Table of Contents | Next

News

Malaria Researchers Wait for Industry to Join Fight

Martin Enserink

A huge toll of illness and death, a dire need for new treatments, and rapid scientific progress are inspiring researchers to battle malaria. But most drug companies balk at investing in what they see as a Third World disease. Some researchers think it's time for the government to step in, perhaps with tax breaks and longer patents for certain drugs on the condition that the revenue be used for new antimalarials.

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
ANTIMALARIAL DRUG RESISTANCE, ARTEMISININ-BASED COMBINATION THERAPY, AND THE CONTRIBUTION OF MODELING TO ELUCIDATING POLICY CHOICES.
S. YEUNG, W. PONGTAVORNPINYO, I. M. HASTINGS, A. J. MILLS, and N. J. WHITE (2004)
Am J Trop Med Hyg 71, 179-186
   Abstract »    Full Text »    PDF »
A yeast-like mRNA capping apparatus in Plasmodiumfalciparum.
C. K. Ho and S. Shuman (2001)
PNAS
   Abstract »    Full Text »
A yeast-like mRNA capping apparatus in Plasmodiumfalciparum.
C. K. Ho and S. Shuman (2001)
PNAS 98, 3050-3055
   Abstract »    Full Text »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)